Journal of Hepatology
Volume 53, Issue 2 , Pages 348-356 , August 2010

Incidence of hepatocellular carcinoma in chronic hepatitis B patients receiving nucleos(t)ide therapy: A systematic review

  • George V. Papatheodoridis

      Affiliations

    • 2nd Department of Internal Medicine, Athens University Medical School, Athens, Greece
    • Corresponding Author InformationCorresponding author. Address: 2nd Department of Internal Medicine, Athens University Medical School, Hippokration General Hospital, 114 Vas. Sophias Ave., 115 27 Athens, Greece. Tel.: +30 210 7774742; fax: +30 210 7706871.
    • ,
  • Pietro Lampertico

      Affiliations

    • 1st Division of Gastroenterology, Fondazione Policlinico IRCCS Ospedale Maggiore, Mangiagalli e Regina Elena, Università degli Studi di Milano Milan, Italy
    • ,
  • Spilios Manolakopoulos

      Affiliations

    • 2nd Department of Internal Medicine, Athens University Medical School, Athens, Greece
    • ,
  • Anna Lok

      Affiliations

    • Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA

  • Image Result

    Incidence of hepatocellular carcinoma (HCC) in chronic hepatitis B patients who were treated with nucleos(t)ide analogue(s) (NUC) for a mean/median of 40 (24–102) months in relation to the presence of

    Incidence of hepatocellular carcinoma (HCC) in chronic hepatitis B patients who were treated with nucleos(t)ide analogue(s) (NUC) for a mean/median of 40 (24–102) months in relation to the presence of cirrhosis, virological remission, and development of lamivudine (LAM) resistance.

PII: S0168-8278(10)00331-4

doi: 10.1016/j.jhep.2010.02.035

Journal of Hepatology
Volume 53, Issue 2 , Pages 348-356 , August 2010

Article Tools

* Image Usage & Resolution